| Zaman aralığı | Tahmini Fiyat | Geçmiş | Tarihsel | İç yüzü |
|---|---|---|---|---|
| Yarın | $34.34 ▲ +1.59% | Dün | $33.57 ▼ -0.67% | Tomorrow's Viking Therapeutics Inc. Common Stock (VKTX) setup is anchored to $33.80 and targets $34.34 (+1.59%). The near-term read is upside; watch $34.81 / $32.79 because daily realized volatility is about 8.00%. |
Tomorrow's Viking Therapeutics Inc. Common Stock (VKTX) setup is anchored to $33.80 and targets $34.34 (+1.59%). The near-term read is upside; watch $34.81 / $32.79 because daily realized volatility is about 8.00%. | ||||
| Hafta | $35.47 ▲ +4.95% | Geçen hafta | $33.10 ▼ -2.08% | The 7-day Viking Therapeutics Inc. Common Stock model moves from $33.10 to $35.47 (+4.95%). It gives upside momentum context for this stock, so breaks around $34.81 / $32.79 matter more than a single tick. |
The 7-day Viking Therapeutics Inc. Common Stock model moves from $33.10 to $35.47 (+4.95%). It gives upside momentum context for this stock, so breaks around $34.81 / $32.79 matter more than a single tick. | ||||
| Ay | $37.36 ▲ +10.54% | Geçen ay | $32.30 ▼ -4.43% | The 1-month Viking Therapeutics Inc. Common Stock target is $37.36 (+10.54%), compared with the live reference near $33.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Viking Therapeutics Inc. Common Stock target is $37.36 (+10.54%), compared with the live reference near $33.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Yıl | $40.20 ▲ +18.93% | Geçen sene | $31.11 ▼ -7.95% | The 1-year Viking Therapeutics Inc. Common Stock scenario points to $40.20 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Viking Therapeutics Inc. Common Stock scenario points to $40.20 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Yıl | $46.84 ▲ +38.57% | 5 Yıl Önce | $28.32 ▼ -16.20% | The 5-year Viking Therapeutics Inc. Common Stock view is $46.84 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Viking Therapeutics Inc. Common Stock view is $46.84 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Gösterge | Değer | Sinyal |
|---|---|---|
| Price | $33.80 | Mid |
| Daily Change | -4.87% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 68% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $33.80 | Daily Change | -4.87% |
| Market Cap | $3.92B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.